|
1
|
Komócsi A, Aradi D, Kehl D, Ungi I, Thury
A, Pintér T, Di Nicolantonio JJ, Tornyos A and Vorobcsuk A:
Meta-analysis of randomized trials on access site selection for
percutaneous coronary intervention in ST-segment elevation
myocardial infarction. Arch Med Sci. 10:203–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee YH, Park JS, Tahk SJ, Hwang GS, Yoon
MH, Choi SY, Choi BJ, Lim HS, Yang HM, Seo KW and Shin JH:
β-blocker therapy in the era of primary percutaneous intervention
for ST elevation myocardial infarction. Cardiology. 132:91–100.
2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Räber L, Taniwaki M, Zaugg S, Kelbæk H,
Roffi M, Holmvang L, Noble S, Pedrazzini G, Moschovitis A, Lüscher
TF, et al: Effect of high-intensity statin therapy on
atherosclerosis in non-infarct-related coronary arteries (IBIS-4):
A serial intravascular ultrasonography study. Eur Heart J.
36:490–500. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Athyros VG, Katsiki N, Karagiannis A and
Mikhailidis DP: Short-, mid-, and long-term benefits of
peri-procedural high-intensity statin administration in patients
undergoing percutaneous coronary intervention. Curr Med Res Opin.
31:191–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yong H, Wang X, Mi L, Guo L, Gao W, Zhang
Y and Cui M: Effects of atorvastatin loading prior to primary
percutaneous coronary intervention on endothelial function and
inflammatory factors in patients with ST-segment elevation
myocardial infarction. Exp Ther Med. 7:316–322. 2014.PubMed/NCBI
|
|
6
|
Celik T, Kursaklioglu H, Iyisoy A, Kose S,
Kilic S, Amasyali B, Kardesoglu E and Isik E: The effects of prior
use of atorvastatin on coronary blood flow after primary
percutaneous coronary intervention in patients presenting with
acute myocardial infarction. Coron Artery Dis. 16:321–326. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leoncini M, Toso A, Maioli M, Tropeano F
and Bellandi F: Statin treatment before percutaneous cononary
intervention. J Thorac Dis. 5:335–342. 2013.PubMed/NCBI
|
|
8
|
Shen W, Shi HM, Fan WH, Luo XP, Jin B and
Li Y: The effects of simvastatin on angiogenesis: Studied by an
original model of atherosclerosis and acute myocardial infarction
in rabbit. Mol Biol Rep. 38:3821–3828. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim JW, Yun KH, Kim EK, Kim YC, Joe DY, Ko
JS, Rhee SJ, Lee EM, Yoo NJ, Kim NH, et al: Effect of high dose
rosuvastatin loading before primary percutaneous coronary
intervention on infarct size in patients with ST-segment elevation
myocardial infarction. Korean Circ J. 44:76–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Benjo AM, El-Hayek GE, Messerli F,
DiNicolantonio JJ, Hong MK, Aziz EF, Herzog E and Tamis-Holland JE:
High dose statin loading prior to percutaneous coronary
intervention decreases cardiovascular events: A meta-analysis of
randomized controlled trials. Catheter Cardiovasc Interv. 85:53–60.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jang Y, Zhu J, Ge J, Kim YJ, Ji C and Lam
W: Preloading with atorvastatin before percutaneous coronary
intervention in statin-naïve Asian patients with non-ST elevation
acute coronary syndromes: A randomized study. J Cardiol.
63:335–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Navarese EP, Kowalewski M, Andreotti F,
van Wely M, Camaro C, Kolodziejczak M, Gorny B, Wirianta J, Kubica
J, Kelm M, et al: Meta-analysis of time-related benefits of statin
therapy in patients with acute coronary syndrome undergoing
percutaneous coronary intervention. Am J Cardiol. 113:1753–1764.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eisen A, Leshem-Lev D, Yavin H, Orvin K,
Mager A, Rechavia E, Bental T, Dadush O, Battler A, Kornowski R and
Lev EI: Effect of high dose statin pretreatment on endothelial
progenitor cells after percutaneous coronary intervention
(HIPOCRATES Study). Cardiovasc Drugs Ther. 29:129–135. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bickel C, Rupprecht HJ, Maimaitiming A,
Welk I, Blankenberg S, Krummenauer F and Meyer J: The superiority
of TIMI frame count in detecting coronary flow changes after
coronary stenting compared to TIMI Flow Classification. J Invasive
Cardiol. 14:590–596. 2002.PubMed/NCBI
|
|
15
|
Alfonso F, Pérez-Vizcayno MJ, Cárdenas A,
García Del Blanco B, García-Touchard A, López-Minguéz JR, Benedicto
A, Masotti M, Zueco J, Iñiguez A, et al: A prospective randomized
trial of drug-eluting balloons versus everolimus-eluting stents in
patients with in-stent restenosis of drug-eluting stents: The RIBS
IV randomized clinical trial. J Am Coll Cardiol. 66:23–33. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lev EI, Kornowski R, Vaknin-Assa H,
Ben-Dor I, Brosh D, Teplitsky I, Fuchs S, Battler A and Assali A:
Effect of previous treatment with statins on outcome of patients
with ST-segment elevation myocardial infarction treated with
primary percutaneous coronary intervention. Am J Cardiol.
103:165–169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ota T, Ishii H, Suzuki S, Tanaka A,
Shibata Y, Tatami Y, Harata S, Shimbo Y, Takayama Y, Kawamura Y, et
al: Relation between paradoxical decrease in high-density
lipoprotein cholesterol levels after statin therapy and adverse
cardiovascular events in patients with acute myocardial infarction.
Am J Cardiol. 115:411–416. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng X, Dreyer RP, Hu S, Spatz ES,
Masoudi FA, Spertus JA, Nasir K, Li X, Li J, Wang S, et al:
Age-specific gender differences in early mortality following
ST-segment elevation myocardial infarction in China. Heart.
101:349–355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen JW, Wang YL and Li HW: Elevated
admission microalbuminuria predicts poor myocardial blood flow and
6-month mortality in ST-segment elevation myocardial infarction
patients undergoing primary percutaneous coronary intervention.
Clin Cardiol. 35:219–224. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong M, Mu N, Guo F, Zhang C, Ren F, Li J,
Tao Z, Yang J and Li G: The beneficial effects of postconditioning
on no-reflow phenomenon after percutaneous coronary intervention in
patients with ST-elevation acute myocardial infarction. J Thromb
Thrombolysis. 38:208–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bonetti PO, Wilson SH, Rodriguez-Porcel M,
Holmes DR Jr, Lerman LO and Lerman A: Simvastatin preserves
myocardial perfusion and coronary microvascular permeability in
experimental hypercholesterolemia independent of lipid lowering. J
Am Coll Cardiol. 40:546–554. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Patti G, Pasceri V, Colonna G, Miglionico
M, Fischetti D, Sardella G, Montinaro A and Di Sciascio G:
Atorvastatin pretreatment improves outcomes in patients with acute
coronary syndromes undergoing early percutaneous coronary
intervention: Results of the ARMYDA-ACS randomized trial. J Am Coll
Cardiol. 49:1272–1278. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mandelzweig L, Battler A, Boyko V, Bueno
H, Danchin N, Filippatos G, Gitt A, Hasdai D, Hasin Y, Marrugat J,
et al: The second Euro Heart Survey on acute coronary syndromes:
Characteristics, treatment, and outcome of patients with ACS in
Europe and the Mediterranean Basin in 2004. Eur Heart J.
27:2285–2293. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee CH, Lee SH, Park JS, Kim YJ, Kim KS,
Chae SC, Kim HS, Choi DJ, Cho MC, Rha SW, et al: Impact of statin
usage patterns on outcomes after percutaneous coronary intervention
in acute myocardial infarction: Korea Working Group on Myocardial
Infarction registry (KorMI) study. J Geriatr Cardiol. 11:93–99.
2014.PubMed/NCBI
|
